The accumulative effects of modifiable risk factors on inflammation and haemostasis

Brain, Behavior, and Immunity

Volumn 22, Issue 7, 2008, Pages 1041-1043

  Hamer, Mark ^a   Stamatakis, Emmanual ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

C reactive protein; Cardiovascular risk; Fibrinogen; Health risk behavior

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOSTASIS; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; ALCOHOL DRINKING; C-REACTIVE PROTEIN; CHOLESTEROL; DATA COLLECTION; EXERCISE; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; HYPERTENSION; INFLAMMATION; LIFE STYLE; LONDON; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 50049096150     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2008.03.003     Document Type: Article

References (17)

1. Aronson D., Avizohar O., Levy Y., Bartha P., Jacob G., and Markiewicz W. Factor analysis of risk variables associated with low-grade inflammation. Atherosclerosis (2008) (Epub ahead of print)
2. Capewell S., Morrison C.E., and McMurray J.J. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 81 (1999) 380-386
3. Emberson J.R., Whincup P.H., Morris R.W., and Walker M. Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias. Eur. Heart J. 24 (2003) 1719-1726
4. Engström G., Hedblad B., Stavenow L., Jonsson S., Lind P., Janzon L., and Lindgärde F. Incidence of obesity-associated cardiovascular disease is related to inflammation-sensitive plasma proteins: a population-based cohort study. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1498-1502
5. Fogarty A.W., Glancy C., Jones S., Lewis S.A., McKeever T.M., and Britton J.R. A prospective study of weight change and systemic inflammation over 9 y. Am. J. Clin. Nutr. 87 (2008) 30-35
6. Hardoon S.L., Whincup P.H., Lennon L.T., Wannamethee S.G., Capewell S., and Morris R.W. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors. Circulation 117 (2008) 598-604
7. Hippisley-Cox J., Coupland C., Vinogradova Y., Robson J., May M., and Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335 (2007) 136
8. Imhof A., Froehlich M., Brenner H., Boeing H., Pepys M.B., and Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 357 (2001) 763-767
9. Magnus P., and Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. Arch. Intern. Med. 161 (2001) 2657-2660
10. Maraldi C., Volpato S., Kritchevsky S.B., Cesari M., Andresen E., Leeuwenburgh C., Harris T.B., Newman A.B., Kanaya A., Johnson K.C., Rodondi N., and Pahor M. Impact of inflammation on the relationship among alcohol consumption, mortality, and cardiac events: the health, aging, and body composition study. Arch. Intern. Med. 166 (2006) 1490-1497
11. Mora S., Cook N., Buring J.E., Ridker P.M., and Lee I.M. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 116 (2007) 2110-2118
12. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., Rifai N., Smith Jr. S.C., Taubert K., Tracy R.P., and Vinicor F. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
13. Pou K.M., Massaro J.M., Hoffmann U., Vasan R.S., Maurovich-Horvat P., Larson M.G., Keaney Jr. J.F., Meigs J.B., Lipinska I., Kathiresan S., Murabito J.M., O'Donnell C.J., Benjamin E.J., and Fox C.S. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116 (2007) 1234-1241
14. Rothwell P.M., and Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J. Neurol. Neurosurg. Psychiatry 64 (1998) 730-735
15. The Scottish Government Statistics. Scottish Health Survey Publications. Available from: (accessed November 2007).
16. Volpato S., Pahor M., Ferrucci L., Simonsick E.M., Guralnik J.M., Kritchevsky S.B., Fellin R., and Harris T.B. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the health, aging, and body composition study. Circulation 109 (2004) 607-612
17. Wannamethee S.G., Lowe G.D., Whincup P.H., Rumley A., Walker M., and Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 105 (2002) 1785-1790